Clinical Scorecard: Impact of Ketogenic Diet Therapy on Reducing Outpatient Anti-Epileptic Medication Costs and Enhancing Parental Satisfaction in Children with Drug-Resistant Epilepsy

At a Glance

Key Highlights

• 21.8% reduction in outpatient anti-epileptic drug costs after 6 months of ketogenic diet therapy.
• Statistically significant cost reduction of Rp 3,757,812 (approximately 235 US$).
• Parental satisfaction with ketogenic diet therapy was evaluated through surveys.

Guideline-Based Recommendations

Diagnosis

• Drug-resistant epilepsy defined as persistent seizures despite at least two tolerated anti-epileptic drugs.

Management

• Consider ketogenic diet therapy as an alternative treatment for drug-resistant epilepsy.

Monitoring & Follow-up

• Evaluate seizure frequency and parental satisfaction during ketogenic diet therapy.

Risks

• Potential concerns regarding the cost and implementation of ketogenic diet therapy.

Patient & Prescribing Data

Children with drug-resistant epilepsy aged 5–18 years.

Incorporating ketogenic diet therapy can lead to significant financial savings in outpatient anti-epileptic medication costs.

Clinical Best Practices

• Implement ketogenic diet therapy in a structured outpatient setting.
• Provide parental education and resources for meal preparation.

Related Resources & Content